Aflac (AFL)
(Delayed Data from NYSE)
$114.50 USD
-0.49 (-0.43%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $114.52 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$114.50 USD
-0.49 (-0.43%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $114.52 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth B Momentum F VGM
Zacks News
3 Dividend Growers to Buy for Passive Income
by Derek Lewis
Companies that consistently boost their dividend payouts reflect a successful and shareholder-friendly nature, opting to share a portion of profits with investors. And that's precisely what these three companies have done over the years.
Aflac (AFL) Up 36% in a Year: More Growth on the Horizon?
by Zacks Equity Research
Aflac (AFL) remains well-poised for growth on productivity gains in its U.S. business, new product launches, technology investments and solid cash reserves.
Buy These 3 Low-Beta Stocks to Navigate Volatility
by Derek Lewis
Adding low-beta stocks can be a great way to counter volatility, as these stocks are less sensitive to the market's overall movements
Here's Why You Should Retain MarketAxess (MKTX) Stock for Now
by Zacks Equity Research
Higher commissions, new data contract revenue, growing international business and improved liquidity poise MarketAxess (MKTX) well for growth.
Manulife's (MFC) John Hancock Launches New Insurance Product
by Zacks Equity Research
Manulife's (MFC) John Hancock enhances its product portfolio by launching the Premier Benefit Indexed Universal Life product.
5 Dividend Aristocrats to Buy as Things Look Dicey for Wall Street
by Tirthankar Chakraborty
As stocks are subjected to bouts of volatility, place bets on dividend aristocrats like Caterpillar (CAT), Abbott Laboratories (ABT), McDonald's (MCD), Aflac (AFL) and Automatic Data Processing (ADP) for steady income.
Unum Group (UNM) Rises 22.4% YTD: More Room for Growth?
by Zacks Equity Research
Unum Group (UNM) stock rallies on the back of favorable benefits experience, higher sales, strong persistency, improved premium income and prudent capital deployment.
AIG's Corebridge (CRBG) to Sell UK Life, Streamlines Operations
by Zacks Equity Research
Corebridge (CRBG) intensifies its focus on core business with the sale of UK Life business to Aviva plc.
Are Finance Stocks Lagging Aflac (AFL) This Year?
by Zacks Equity Research
Here is how Aflac (AFL) and Axis Capital (AXS) have performed compared to their sector so far this year.
CNO Financial (CNO) Gains 26% in a Year: More Room to Run?
by Zacks Equity Research
CNO Financial (CNO) is well-poised for growth on a diversified product portfolio, product launches and the prudent deployment of capital.
Seeking Income? 3 Top-Ranked Dividend Aristocrats to Buy
by Derek Lewis
Many investors pivot to the Dividend Aristocrats when looking to generate an income stream. And recently, analysts have become bullish on these three.
Zacks Investment Ideas feature highlights: Caterpillar, Alibaba and Aflac
by Zacks Equity Research
Caterpillar, Alibaba and Aflac are part of the Zacks Investment Ideas article.
3 Large-Caps to Buy for a Steady Approach
by Derek Lewis
Large-caps carry a well-established nature, have greater analyst coverage, and commonly pay dividends, all of which make them so popular. And for those seeking exposure, analysts have recently become bullish on these three.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Aflac (AFL) have what it takes? Let's find out.
Virtu Financial (VIRT) & SMTAM Unite to Improve Trading Workflow
by Zacks Equity Research
Virtu Financial (VIRT) collaborates with Sumitomo Mitsui Trust Asset Management to integrate its investment suite to improve workflows.
Lincoln National (LNC) Stock Up 8.7% in 3 months: Here's Why
by Zacks Equity Research
Lincoln National's (LNC) improving net investment income and strong Group Protection business poise the company well for growth.
Here's Why You Should Retain Coinbase Global (COIN) Stock Now
by Zacks Equity Research
Coinbase Global (COIN) is expected to benefit from reduced operating expenses and an enhanced product suite in the future.
Reasons to Hold American International (AIG) Stock Right Now
by Zacks Equity Research
Streamlining of operations, improving premiums and increasing rates poise American International (AIG) well for growth.
Here's Why Investors Should Retain Hartford Financial (HIG)
by Zacks Equity Research
Hartford Financial (HIG) remains well-poised for growth on the back of strength in its Commercial Lines and Group Benefits businesses. A strong financial position enables business investments.
Why Is Aflac (AFL) Down 2.1% Since Last Earnings Report?
by Zacks Equity Research
Aflac (AFL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Aflac (AFL) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Aflac (AFL) have what it takes? Let's find out.
Manulife (MFC) Enhances Product Suite With New Medicine Program
by Zacks Equity Research
Manulife (MFC) launches Personalized Medicine Program for Enhanced Health Care members in Canada.
Here's Why You Should Add Primerica (PRI) to Your Portfolio
by Zacks Equity Research
Higher premiums in term life insurance, increasing sales force and improving senior health business should poise Primerica (PRI) well for growth.
Here's Why You Should Retain AMERISAFE (AMSF) Stock Now
by Zacks Equity Research
Improving retention, a high-interest rate environment and a robust balance sheet poise AMERISAFE (AMSF) well for growth.
MetLife (MET), Empathy to Offer Enhanced Bereavement Services
by Zacks Equity Research
MetLife (MET) makes Empathy's bereavement care platform available to its customers so that families can better handle administrative hassles and get emotional support following the loss of a loved one.